PE ratio:
19.80-0.17(-0.85%)Summary
- As of today (July 3, 2025), GSK price to earnings ratio is 19.80, with a fall of -0.17 (-0.85%) during the most recent trading session on July 3, 2025.
- Over the past year, GSK PE ratio has increased by +4.27 (+27.50%).
- GSK PE ratio is now -98.56% below its all-time high of 1376.28.
Performance
GSK PE ratio Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
Range
PE ratio Formula
P/E = Price
TTM Earnings Per Share
Price
TTM Earnings Per Share
TTM Earnings Per Share
GSK PE ratio Trends
| PeriodPeriod | PE ratioPE ratio | PricePrice | TTM EPSTTM EPS | TTM revenueTTM revenue |
|---|---|---|---|---|
| todaytoday | -0.8% | -0.9% | +21.8% | +0.3% |
| 1 m1 month | -5.6% | -5.6% | - | - |
| 3 m3 months | -2.1% | -2.1% | +21.8% | +0.3% |
| 6 m6 months | -6.3% | +14.1% | - | - |
| ytdytd | -7.3% | +12.9% | - | - |
| 1 y1 year | +27.5% | -0.7% | -29.9% | +4.1% |
| 5 y5 years | +97.0% | -9.2% | -53.9% | -8.8% |
GSK PE ratio Highs & Lows
| PeriodPeriod | HighHigh | Current vs highvs high | LowLow | Current vs lowvs low | |
|---|---|---|---|---|---|
| 1 m | 1-month | 22.03 | -10.1% | 19.74 | +0.3% |
| 3 m | 3-month | 22.03 | -10.1% | 17.42 | +13.7% |
| 6 m | 6-month | 25.51 | -22.4% | 17.42 | +13.7% |
| 1 y | 1-year | 26.58 | -25.5% | 15.53 | +27.5% |
| 3 y | 3-year | 26.58 | -25.5% | 3.53 | +460.9% |
| 5 y | 5-year | 26.58 | -25.5% | 3.53 | +460.9% |
| alltime | all time | 1376.28 | -98.6% | 3.53 | +460.9% |
GSK PE ratio History
| Date | Value |
|---|---|
| 2025 | 19.80(-7.3%) |
| 2024 | 21.36(+72.5%) |
| 2023 | 12.38(+206.4%) |
| 2022 | 4.04(-73.2%) |
| 2021 | 15.05(+45.8%) |
| 2020 | 10.32(-36.4%) |
| 2019 | 16.22(0.0%) |
| 2018 | 16.22(-56.3%) |
| 2017 | 37.11(-44.5%) |
| 2016 | 66.81(+967.3%) |
| 2015 | 6.26(-66.7%) |
| 2014 | 18.82(+51.4%) |
| 2013 | 12.43(+0.4%) |
| 2012 | 12.38(+10.1%) |
| 2011 | 11.24(-65.5%) |
| 2010 | 32.54(+221.5%) |
| 2009 | 10.12(+9.3%) |
| 2008 | 9.26(-15.2%) |
| 2007 | 10.92(-11.6%) |
| 2006 | 12.35(-10.6%) |
| Date | Value |
|---|---|
| 2005 | 13.82(-11.7%) |
| 2004 | 15.65(+3.5%) |
| 2003 | 15.12(-2.2%) |
| 2002 | 15.46(-45.2%) |
| 2001 | 28.20(+24.0%) |
| 2000 | 22.74(-17.4%) |
| 1999 | 27.54(-19.0%) |
| 1998 | 33.98(+44.2%) |
| 1997 | 23.56(+64.0%) |
| 1996 | 14.37(-33.7%) |
| 1995 | 21.68(+42.5%) |
| 1994 | 15.21(+17.6%) |
| 1993 | 12.93(-22.6%) |
| 1992 | 16.71(-60.7%) |
| 1991 | 42.54(+18.2%) |
| 1990 | 35.98(+3.4%) |
| 1989 | 34.81(+23.0%) |
| 1988 | 28.31(-6.5%) |
| 1987 | 30.29(-18.4%) |
| 1986 | 37.11(-55.2%) |
| 1985 | 82.81 |
FAQ
- What is GSK price to earnings ratio?
- What is the all time high PE ratio for GSK?
- What is GSK price to earnings ratio year-to-date change?
- What is GSK PE ratio year-on-year change?
What is GSK price to earnings ratio?
The current PE ratio of GSK is 19.80
What is the all time high PE ratio for GSK?
GSK all-time high price to earnings ratio is 1376.28
What is GSK price to earnings ratio year-to-date change?
GSK price to earnings ratio has changed by -1.56 (-7.30%) since the beginning of the year
What is GSK PE ratio year-on-year change?
Over the past year, GSK price to earnings ratio has changed by +4.27 (+27.50%)